SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Innova Captab - Quaterly Results

07 Aug 2025 Evaluate
The sales for the June 2025 quarter moved up 26.52% to Rs. 2869.79 millions as compared to Rs. 2268.32 millions during the corresponding quarter last year.The Company's Net profit for the June 2025 quarter have declined marginally to Rs. 202.95  millions as against Rs. 223.36 millions reported during the corresponding quarter ended.OP of the company witnessed a marginal growth to 391.36 millions from 330.89 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 2869.79 2268.32 26.52 2869.79 2268.32 26.52 9580.61 8649.29 10.77
Other Income 43.15 46.43 -7.06 43.15 46.43 -7.06 167.75 107.18 56.51
PBIDT 391.36 330.89 18.27 391.36 330.89 18.27 1390.74 1186.88 17.18
Interest 27.68 0.89 3010.11 27.68 0.89 3010.11 21.68 135.91 -84.05
PBDT 363.68 330.00 10.21 363.68 330.00 10.21 1369.06 1050.97 30.27
Depreciation 90.76 30.55 197.09 90.76 30.55 197.09 170.15 113.99 49.27
PBT 272.92 299.45 -8.86 272.92 299.45 -8.86 1198.91 936.98 27.95
TAX 69.97 76.09 -8.04 69.97 76.09 -8.04 304.21 255.37 19.13
Deferred Tax 18.75 28.85 -35.01 18.75 28.85 -35.01 84.21 3.53 2285.55
PAT 202.95 223.36 -9.14 202.95 223.36 -9.14 894.70 681.61 31.26
Equity 572.25 572.25 0.00 572.25 572.25 0.00 572.25 572.25 0.00
PBIDTM(%) 13.64 14.59 -6.51 13.64 14.59 -6.51 14.52 13.72 5.79

Innova Captab Share Price

689.85 11.25 (1.66%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×